drugset / Trial / NCT05738291
A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the Blood
RandomizedParallel-groupSingle-blindTreatment
Summary
Effects of multiple rising doses of BI 1839100 on safety, tolerability, pharmacokinetics and the effect of high-fat meal on pharmacokinetics of BI 1839100 will be assessed as well as assessing potential drug-drug interactions.
Timeline
- Start
- 2023-05-01
- Primary completion
- 2024-06-14
- Completion
- 2024-06-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1839100 | Unknown | — | — |
| Subject | Digoxin | Other / unclassified | — | — |
| Subject | Midazolam | Small molecule | — | — |
| Subject | Rosuvastatin | Small molecule | — | — |
Indications
No indication recorded.